Shalini Rao
Senior Principal Scientist


Shalini is a Senior Principal Scientist at Azeria. Shalini has over 10 years of experience in oncology research and drug discovery and was formally at the University of Cambridge, where she led pre-clinical drug development work using in vivo models of breast and pancreatic cancer. Prior to this Shalini undertook an innovation postdoctoral fellowship funded by the Research Council of Norway exploring the utility and commercial potential of a novel anti-cancer agent. Shalini’s areas of expertise include target validation, functional genomics, and the use of advanced in vivo cancer models for the development and testing of novel therapeutics. Shalini has widely published in leading journals including Nature Genetics and BMC Cancer.